A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...